How do I write an order for a repeat venous duplex ultrasound (Doppler) of the proximal to mid left brachial vein to assess for residual deep vein thrombosis after a 3‑month course of apixaban (Eliquis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Order a Repeat Doppler Study After DVT Treatment

Order a venous duplex ultrasound (complete duplex ultrasound with compression) of the left upper extremity, specifically evaluating the proximal to mid left brachial vein, to establish a new baseline and assess for chronic post-thrombotic changes versus residual thrombosis after completion of 3 months of anticoagulation therapy for deep vein thrombosis.

Rationale for Ordering This Study

The Society of Radiologists in Ultrasound (SRU) 2018 consensus guidelines specifically recommend that repeat ultrasound at or near the end of anticoagulation is appropriate to establish a new baseline and to determine if scarring is present 1. This is particularly important for your patient because:

  • Establishing a baseline is critical for future comparison: If your patient develops new symptoms later, you'll need to distinguish between chronic post-thrombotic changes (scarring) versus new acute DVT—a distinction that's nearly impossible without a baseline study 1
  • Residual thrombosis predicts recurrence risk: Research shows that persistent residual thrombosis at 3 months is associated with a 2.4-fold increased risk of recurrent thromboembolism (hazard ratio 2.4,95% CI 1.3-4.4) 2
  • May guide extended anticoagulation decisions: While the 2020 ASH guidelines suggest against routine use of ultrasound to guide duration of therapy 3, the presence of residual thrombosis may inform discussions about extended prophylaxis with reduced-dose apixaban (2.5 mg twice daily) 4, 5

Important Caveats About Upper Extremity DVT

Note that the SRU guidelines focus primarily on lower extremity DVT 1. For upper extremity evaluation, the ACR Appropriateness Criteria (2020) confirm that ultrasound duplex Doppler is the most appropriate imaging modality for upper-extremity DVT 6. The same principles regarding baseline imaging and chronic changes apply, though the evidence base is smaller.

Timing Considerations

Order this study at or near the completion of the 3-month treatment course, ideally within the last 1-2 weeks of anticoagulation or shortly after stopping 1. The guidelines explicitly state that imaging while on adequate anticoagulation is unwarranted unless it will change the patient's treatment 1.

What the Radiologist Should Report

The study should specifically assess and report:

  • Vein compressibility in the affected segments
  • Presence of chronic post-thrombotic changes (the preferred terminology rather than "chronic thrombus" or "residual thrombus") 1
  • Degree of recanalization versus persistent occlusion
  • Baseline vein diameter for future comparison
  • Flow characteristics on spectral Doppler

Clinical Pitfall to Avoid

Do not confuse chronic post-thrombotic changes with acute DVT. Both can cause noncompressibility on ultrasound 1. Chronic changes typically show:

  • Smaller, flatter intraluminal material
  • Partial lumen reconstitution
  • Scarring and wall thickening

Whereas acute DVT shows:

  • Soft, deformable thrombus
  • Smooth surface
  • Vein larger than normal
  • Distended vein

Sample Order Language

"Venous duplex ultrasound of left upper extremity with complete evaluation of the brachial vein (proximal to mid segments). Clinical indication: Establish baseline after completion of 3-month anticoagulation for acute DVT. Please assess for residual thrombosis versus chronic post-thrombotic changes and document degree of recanalization."

Related Questions

In a 74-year-old bedridden woman with a prior history of deep vein thrombosis treated with apixaban (Eliquis) for 7 months and chronic residual thrombosis, and a current duplex ultrasound showing no acute DVT, should anticoagulation be restarted?
Can apixaban be used to treat deep vein thrombosis in an adult leukemia patient with platelet count ≥50 × 10⁹/L and creatinine clearance ≥30 mL/min, and what dosing and monitoring are recommended?
How should a 78-year-old man with prior deep vein thrombosis six months ago, who completed a three-month course of apixaban (Eliquis) and now presents with three-day left lower extremity swelling and occasional pain without redness or warmth, be managed?
What estrogen‑free contraceptive options are appropriate for a 19‑year‑old woman with a new left‑leg deep vein thrombosis who is taking apixaban (Eliquis)?
What is the appropriate apixaban dosing regimen for a 16‑kg child with a proximal deep vein thrombosis?
How should vitamin D be repleted in a patient with a serum 25‑hydroxyvitamin D level of 7 ng/mL?
Can I take an over‑the‑counter cough syrup together with Tessalon Perles (benzonatate)?
What is the appropriate treatment for a 25‑hydroxyvitamin D level of 17 ng/mL?
What is the expected healing timeline for my post‑priapic penile changes after a prolonged erection caused by combined tadalafil (Cialis) and sildenafil (Viagra) use?
Can Ozempic (semaglutide) be used during the first trimester of pregnancy in a patient who is 6 weeks and 2 days pregnant with a viable intrauterine pregnancy?
What is the likely diagnosis and recommended initial management for a 59-year-old man with spontaneous bilateral heel pain that is extremely tender to palpation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.